Add to Calendar
5/5/2022 8:30:00 AM5/5/2022 8:30:00 PM 2022 State of Possible Conference MassBio's annual State of Possible Conference celebrates how the life sciences make the impossible possible. We will tap today’s brightest minds for engaging conversations on the latest developments in our industry, key insights from the past year, and building a better future for patients around the world. This year's conference will explore the theme "The Massachusetts BioPharma Ecosystem in the Post- Covid Era."
Join MassBio and more than 500 attendees for a day of networking, keynotes, and panel discussions from some of the most inspiring voices in the industry, culminating in a reception celebrating the life sciences community. This is our most popular event so you will want to reserve your spot early.
Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Vice President, Early Development, Sage Therapeutics
Helen is currently Vice President, Early Development at Sage Therapeutics, a company whose vision it is to fearlessly lead the way to create a world with better brain health. Helen led the development program at Sage that culminated in FDA approval of Zulresso for the treatment of Post-partum Depression. Helen’s current responsibilities include oversight of the transition of programs from Research into Development and through Early Development. Helen’s career has included working for large and small biotechnology and pharma companies, as well as work in consulting and medical devices.